Pouya Javadian

Dr. Pouya Javadian

University of Oklahoma Health Sciences Center (OUHSC)
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ASAlireza A. Shamshirsaz
Alireza A. Shamshirsaz
KFKarin A. Fox
Karin A. Fox
BSBahram Salmanian
Bahram Salmanian
CDConcepcion R. Diaz-Arrastia
Concepcion R. Diaz-Arrastia
WLWesley Lee
Wesley Lee
MBMichael A. Belfort
Michael A. Belfort

3 November 2021 in Cells
Verified
Journal Article
Open access
PDF file
RRRajani Rai
Rajani Rai
AKAmy Kennedy
Amy Kennedy
ZIZitha Redempta Isingizwe
Zitha Redempta Isingizwe
PJPouya Javadian
Pouya Javadian
Doris Mangiaracina BenbrookDoris Mangiaracina Benbrook
Doris Mangiaracina Benbrook
Background: Upregulation of Heath Shock Protein 70 (HSP70) chaperones supports cancer cell survival. Their high homology causes a challenge to differentiate them in experimental or prevention and treatment strategies. The objective of this investigation was to determine similarities and differences of Hsp70, hsc70, Grp78 and Mortalin members of the HSP70 family encoded by HSPA1, HSPA8, HSPA5 and HSPA9 genes, respectively. Methods: Literature reviews were conducted using HSPA1, HSPA5, HSPA8 and HSPA9 gene or protein names or synonyms combined with biological or cancer-relevant terms. Ingenuity Pathway Analysis was used to identify and compare profiles of proteins that directly bind individual chaperones and their associated pathways. TCGA data was probed to identify associations of hsc70 with cancer patient survival. ClinicalTrials.gov was used to identify HSP70 family studies. Results: The chaperones have similar protein folding functions. Their different cellular effects are determined by co-chaperones and client proteins combined with their intra- and extra-cellular localizations. Their upregulation is associated with worse patient prognosis in multiple cancers and can stimulate tumor immune responses or drug resistance. Their inhibition selectively kills cancer over healthy cells. Conclusions: Differences in Hsp70, hsc70, Grp78 and mortalin provide opportunities to calibrate HSP70 inhibitors for individual cancers and combination therapies.

23 September 2013 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
PJPouya Javadian
Pouya Javadian
ASAlireza A. Shamshirsaz
Alireza A. Shamshirsaz
SHS. Haeri
S. Haeri
RRR. Ruano
R. Ruano
SRS. M. Ramin
S. M. Ramin
MBM. A. Belfort
M. A. Belfort

18 August 2011 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
SHSedigheh Hantoushzadeh
Sedigheh Hantoushzadeh
FGFateme Golshahi
Fateme Golshahi
PJPouya Javadian
Pouya Javadian
SKSoghra Khazardoost
Soghra Khazardoost
SAShahnaz Aram
Shahnaz Aram
SBSedigheh Borna
Sedigheh Borna
Objective: This study was performed to determine the comparative efficacy of probiotic yoghurt and clindamycin in the treatment of bacterial vaginosis in pregnant women in the third trimester. Methods and materials: This randomized clinical trial was performed as an open-label study. 310 symptomatic patients with BV were recruited. Diagnosis of BV was through Amsel criteria. The patients were randomly assigned to receive either probiotic yoghurt (100 g twice a day/week) or orally administered clindamycin (300 mg twice a day/week). Results: Ten patients in probiotic group and 9 subjects in clindamycin group had symptom recurrence (p > 0.05). 132 patients in probiotic group and 105 subjects in clindamycin group had pH decrease (p < 0.0001). 140 patients in probiotic group and 141 subjects in clindamycin group had complete symptomatic cure (p > 0.05). Twelve patients in probiotic group and seven subjects in clindamycin group had preterm birth. Nine women in probiotic group and five subjects in clindamycin group had PROM (p > 0.05). Conclusions: According to the obtained results, it may be concluded that probiotics would have a good efficacy in the treatment of bacterial vaginosis in pregnancy leading to decreased burden of subsequent preterm birth.

3 June 2016 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
NSN. Sananes
N. Sananes
PJPouya Javadian
Pouya Javadian
IBI. Schwach Werneck Britto
I. Schwach Werneck Britto
NMN. Meyer
N. Meyer
AKA. Koch
A. Koch
RRRodrigo Ruano
Rodrigo Ruano

1 June 2013 in Journal of Reproductive Immunology
Verified
Journal Article
Closed access
SAShohreh Alimohamadi
Shohreh Alimohamadi
PJPouya Javadian
Pouya Javadian
MGMohammad Hadi Gharedaghi
Mohammad Hadi Gharedaghi
NJNima Javadian
Nima Javadian
HAHossein Alinia
Hossein Alinia
SHSedigheh Hantoushzadeh
Sedigheh Hantoushzadeh